Home
>
National Drug Code (NDC)
>
TACLONEX
TACLONEX - 50222-501-51 - (calcipotriene and betamethasone dipropionate)
Drug Information of TACLONEX
| Product NDC: | 50222-501 |
| Proprietary Name: | TACLONEX |
| Non Proprietary Name: | calcipotriene and betamethasone dipropionate |
| Active Ingredient(s): | .5; 50 mg/g; ug/g & nbsp; calcipotriene and betamethasone dipropionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TACLONEX
| Product NDC: | 50222-501 |
| Labeler Name: | LEO Pharma Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022185 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080601 |
Package Information of TACLONEX
| Package NDC: | 50222-501-51 |
| Package Description: | 40 CARTON in 1 CASE (50222-501-51) > 1 BOTTLE in 1 CARTON > 4 g in 1 BOTTLE |
NDC Information of TACLONEX
| NDC Code | 50222-501-51 |
| Proprietary Name | TACLONEX |
| Package Description | 40 CARTON in 1 CASE (50222-501-51) > 1 BOTTLE in 1 CARTON > 4 g in 1 BOTTLE |
| Product NDC | 50222-501 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | calcipotriene and betamethasone dipropionate |
| Dosage Form Name | SUSPENSION |
| Route Name | TOPICAL |
| Start Marketing Date | 20080601 |
| Marketing Category Name | NDA |
| Labeler Name | LEO Pharma Inc. |
| Substance Name | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE |
| Strength Number | .5; 50 |
| Strength Unit | mg/g; ug/g |
| Pharmaceutical Classes | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
